Literature DB >> 27705736

MLL translocation in two castration-resistant prostate cancer patients.

Rajasree Pia Chowdry1, Elisa Ledet, Lahiru Ranasinghe, Alton Oliver Sartor.   

Abstract

The mixed-lineage leukemia (MLL) protein acts as a histone methyltransferase regulating multiple genetic elements. Rearrangements of the MLL gene result in expression of MLL-fusion proteins that occur in some acute leukemias and are associated with poor prognosis. The MLL protein complex has been shown to interact with the androgen receptor via the MLL-menin subunit, thus promoting gene activation. The presence of MLL translocation has not been previously reported in patients with castrate resistant prostate cancer (CRPC). We describe two cases of metastatic CRPC with a translocation in the MLL gene detected by a specific fluorescent in situ hybridization (FISH) assay. Both patients had an aggressive course and succumbed to the illness.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27705736

Source DB:  PubMed          Journal:  Can J Urol        ISSN: 1195-9479            Impact factor:   1.344


  2 in total

1.  Oncogenic and osteolytic functions of histone demethylase NO66 in castration-resistant prostate cancer.

Authors:  Krishna M Sinha; Rozita Bagheri-Yarmand; Sharmistha Lahiri; Yue Lu; Miao Zhang; Sarah Amra; Yasmeen Rizvi; Xinhai Wan; Nora Navone; Bulent Ozpolat; Christopher Logothetis; Robert F Gagel; Johnny Huard
Journal:  Oncogene       Date:  2019-03-11       Impact factor: 9.867

2.  Molecular characterization of an MLL1 fusion and its role in chromosomal instability.

Authors:  Sreejit Parameswaran; Frederick S Vizeacoumar; Kalpana Kalyanasundaram Bhanumathy; Fujun Qin; Md Fahmid Islam; Behzad M Toosi; Chelsea E Cunningham; Darrell D Mousseau; Maruti C Uppalapati; Peter C Stirling; Yuliang Wu; Keith Bonham; Andrew Freywald; Hui Li; Franco J Vizeacoumar
Journal:  Mol Oncol       Date:  2018-12-31       Impact factor: 6.603

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.